XML 78 R63.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholder's equity (Details)
€ / shares in Units, $ / shares in Units, € in Millions
2 Months Ended 12 Months Ended
Mar. 01, 2021
USD ($)
Apr. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / €
shares
Dec. 31, 2021
USD ($)
Dec. 31, 2022
EUR (€)
€ / shares
$ / €
shares
Dec. 31, 2021
€ / shares
Dec. 31, 2021
USD ($)
shares
Jun. 16, 2021
shares
Dec. 31, 2020
USD ($)
Authorized share capital     $ 4,300,000   € 4.0        
Common stock, additional shares authorized | shares               20,000,000  
Exchange rate (in USD per Euro) | $ / €     1.07   1.07        
Ordinary shares, authorized | shares     80,000,000   80,000,000   80,000,000    
Ordinary shares, par value (in euros per share) | € / shares         € 0.05 € 0.05      
Accumulated other comprehensive loss     $ (58,291,000)       $ (28,856,000)   $ (9,900,000)
Aggregate offering price       $ 29,564,000          
Income tax benefit of past share issuance cost     808,000 3,047,000          
Increase of additional paid in capital     800,000            
Sales Agreement with SVB Leerink LLC                  
Percentage of gross proceeds 3.00%                
Sales Agreement with SVB Leerink LLC | Direct Incremental Labor                  
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs     $ 0 $ 1,300,000          
Sales Agreement with SVB Leerink LLC | Ordinary shares                  
Shares issued in connection with offering | shares   921,730              
Share price (in dollars per share) | $ / shares   $ 33.52              
Net proceeds   $ 29,600,000              
Sales Agreement with SVB Leerink LLC | Maximum                  
Aggregate offering price $ 200,000,000.0